The long term goal of our investigations is the elucidation of the relationship between chemical structure, conformation, receptor binding and biological activity (metabolic and growth-promoting) of insulin. Our studies thus far provided data suggesting: a) that within the insulin molecule there is one region primarily associated with receptor binding (""""""""binding region"""""""") and another region associated with the expression of biological activity (""""""""message region""""""""); b) that the C-terminal region of the A chain may be involved in the expression of the biological activity of insulin; and c) that insulin analogues exhibiting a wide range of biological activities, by circular dichroism reveal little if any conformational difference from monomeric insulin. It is our objective to identify those structural features or amino acid residues involved in the functional regions of insulin and to delineate the conformational differences betwen insulin and analogue which would account for the differences in their biological behavior.
The specific aims i nclude: (1) The synthesis of insulin analogues bearing modifications that will affect directly or indirectly the C-terminal region of the A chain; (2) The snythesis of analogues bearing modification that will affect the stability of the B20-B23 Beta-turn; (3) The snythesis of analogues in which selected peptide bonds, predicted by computer graphics to be involved in receptor binding, will be modified; (4) The synthesis of analogues incorporating unique structural features found in the strongly growth-promoting insulin-like growth factors and hystricomorph insulins. These latter modifications may lead to """"""""new insulins"""""""" with enhancd mitogenic activities; (5) Comparison of the conformation of the monomeric form of insulin with that of insulin analogues, known to be monomeric, by nanosecond time-resolved fluorescence. We will assess to what extent the conformation of insulin in solution is comparable to the conformation of the analogues by measuring the fluorescene lifetimes and anisotropy decay of their tyrosine resides; (6) Measure the time-resolved fluorescence of insulin analogues in which individual tyrosine residues are substituted with residues having special photophysical properties.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK012925-17
Application #
3224949
Study Section
Bio-Organic and Natural Products Chemistry Study Section (BNP)
Project Start
1976-12-01
Project End
1989-11-30
Budget Start
1985-12-01
Budget End
1986-11-30
Support Year
17
Fiscal Year
1986
Total Cost
Indirect Cost
Name
Mount Sinai School of Medicine
Department
Type
Schools of Medicine
DUNS #
City
New York
State
NY
Country
United States
Zip Code
10029
Weiss, Michael A; Nakagawa, Satoe H; Jia, Wenhua et al. (2002) Protein structure and the spandrels of San Marco: insulin's receptor-binding surface is buttressed by an invariant leucine essential for its stability. Biochemistry 41:809-19
Hua, Q X; Hu, S Q; Jia, W et al. (1998) Mini-proinsulin and mini-IGF-I: homologous protein sequences encoding non-homologous structures. J Mol Biol 277:103-18
Hua, Q X; Hu, S Q; Frank, B H et al. (1996) Mapping the functional surface of insulin by design: structure and function of a novel A-chain analogue. J Mol Biol 264:390-403
Laws, W R; Schwartz, G P; Rusinova, E et al. (1995) 5-Hydroxytryptophan: an absorption and fluorescence probe which is a conservative replacement for [A14 tyrosine] in insulin. J Protein Chem 14:225-32
Chu, Y C; Hu, S Q; Zong, L et al. (1994) Insulin-like compounds related to the amphioxus insulin-like peptide. Biochemistry 33:11278-85
Chu, Y C; Burke, G T; Gammeltoft, S et al. (1994) High-potency hybrid compounds related to insulin and amphioxus insulin-like peptide. Biochemistry 33:13087-92
Kurose, T; Pashmforoush, M; Yoshimasa, Y et al. (1994) Cross-linking of a B25 azidophenylalanine insulin derivative to the carboxyl-terminal region of the alpha-subunit of the insulin receptor. Identification of a new insulin-binding domain in the insulin receptor. J Biol Chem 269:29190-7
Hu, S Q; Burke, G T; Schwartz, G P et al. (1993) Steric requirements at position B12 for high biological activity in insulin. Biochemistry 32:2631-5
Hu, S Q; Burke, G T; Katsoyannis, P G (1993) Contribution of the B16 and B26 tyrosine residues to the biological activity of insulin. J Protein Chem 12:741-7
Chu, Y C; Burke, G T; Ross, J B et al. (1993) The effect of placement of tryptophan residues in selected A-chain positions on the biological profile of insulin. J Protein Chem 12:499-505

Showing the most recent 10 out of 23 publications